Both in Pharmaceuticals
Contineum Therapeutics vs Lyell Immunopharma
Over the past year CTNM returned −5.8% and LYEL returned −3.3%; their daily moves had a correlation of 0.24.
CTNM −5.8% LYEL −3.3%Growth of $1, one year, split-adjusted
| Metric | CTNM | LYEL |
|---|---|---|
| Price | $9.79 | $15.43 |
| Market cap | $368.3M | $378.1M |
| Today | +1.03% | +43.27% |
| 1 month | −22.6% | +79.2% |
| 6 months | −34.5% | −26.0% |
| Year to date | −14.3% | −49.9% |
| 1 year | −8.1% | −6.8% |
| Revenue growth (YoY) | — | −50.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −1118875.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 14,004.2× |
| Net cash | $236.6M | $204.1M |
| Dividend yield | — | — |
| Volatility (60d) | 117.4% | 101.1% |
| Short % of float | 13.1% | 15.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).